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CRRT efficiency and efficacy in relation to solute size. Removal SMALL SOLUTE REMOVAL IN CRRT
of blood solutes in patients with decreased or absent glomerular Interaction between diffusion and convection:filtration is the prime objective of continuous renal replacement
Intermittent hemodialysis versus CRRTtherapies (CRRTs). However, because these blood solutes are
of different molecular weights, factors such as the porosity and In both intermittent hemodialysis (IHD) and some con-
hydrophobicity of the filter membranes and the extracorporeal tinuous therapies, solute removal by diffusion and convec-
flow rates determine the CRRT that is the most effective filtra- tion occurs simultaneously. In IHD, the use of high blood
tion system. This article discusses both small and large solute
and dialysate flow rates results in relatively high smallremoval, the interaction of convection and diffusion, and the
solute clearances. These clearances are primarily diffu-potential for CRRTs to remove particular inflammatory media-
sive in nature but there is also a convective componenttors of acute renal failure.
related to plasma water ultrafiltration. In IHD, diffusion
and convection interact in such a manner that total solute
removal is significantly less than what is expected if theOne of the foremost objectives of renal replacement
individual components are simply added together, a phe-therapy in patients with acute renal failure (ARF) is the
nomenon explained in the following way. Diffusive sol-removal of blood solutes that are retained as a conse-
ute removal results in a decrease in solute concentrationquence of decreased or absent glomerular filtration. Sol-
in the blood compartment along the axial length (thatute removal can occur by several different mechanisms
is, from blood inlet to blood outlet) of the hemodialyzer.in continuous renal replacement therapy (CRRT). The
As convective removal is directly proportional to the
ability of a specific CRRT to remove a certain solute or blood compartment concentration of the solute, convec-
class of solutes is determined by numerous treatment tive removal decreases as a function of this axial concen-
parameters. Important among these parameters are filter tration gradient. On the other hand, hemoconcentration
membrane characteristics, such as porosity and hydro- resulting from ultrafiltration of plasma water causes a
phobicity, and the extracorporeal flow rates (blood, dial- progressive increase in plasma protein concentration and
ysate, and ultrafiltration) used. hematocrit along the axial length of the filter. This hemo-
The purpose of this article is to provide an overview concentration and associated hyperviscosity cause an in-
of the factors determining the removal of solutes by crease in diffusive mass transfer resistance and a decrease
CRRT over a broad molecular weight range. For rela- in solute transport by this mechanism. Numerous investi-
tively small solutes, the effect of increasing dialysate flow gators have analyzed the effect of this interaction on
rate on continuous venovenous hemodialysis (CVVHD) overall solute removal in IHD [1, 2]. The most useful
efficiency is discussed. The potential interaction between analysis has been performed by Jaffrin [2]:
diffusion and convection for small solutes in CRRT is
KT 5 KD 1 (QF · Tr)also discussed. For solutes of larger molecular weight, the
In this equation, KT is total solute clearance, KD is diffu-importance of convection and adsorption is emphasized.
sive clearance under conditions of no ultrafiltration, andFinally, the issue of inflammatory mediator removal by
the final term is the convective component of clearance.convective CRRT is presented. For some of these issues,
The latter term is a function of the ultrafiltration rateinformation learned in the chronic hemodialysis setting
(QF) and an experimentally derived transmittance coef-will provide a reference base.
ficient (Tr):
Tr 5 S (1 2 KD/QB)
Key words: solute, clearance, diffusion, convection, membrane, hemo-
filtration. where S is the solute sieving coefficient. Thus, Tr for a
particular solute is dependent on the efficiency of diffusive 1999 by the International Society of Nephrology
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removal. At very low values of KD/QB, diffusion has a
very small impact on blood compartment concentrations
and the convective component of clearance closely ap-
proximates the quantity S·QF. However, with increasing
efficiency of diffusive removal (that is, increasing KD/QB),
blood compartment concentrations are significantly in-
fluenced. The result is a decrease in Tr and, consequently,
in the convective contribution to total clearance.
Due to the markedly lower flow rates used in CRRT,
the effect of simultaneous diffusion and convection on
overall solute removal is quite different. Based on a
comparison of urea, the diffusive clearance in continuous
arteriovenous hemodialysis (CAVHD), CVVHD, and
continuous venovenous hemodiafiltration (CVVHDF;
typically 17 to 34 ml/min) [3–7] is only approximately 5
to 15% of that achieved in IHD. Therefore, the small
solute concentration gradient along the axial length of the
filter (that is, extraction) is minimal compared to that
which is seen in an IHD setting, in which extraction
ratios of 50% or more are the norm.
In a classic clinical study published over a decade ago,
Sigler and Teehan specifically assessed the potential in-
Fig. 1. Components of urea clearance in continuous arteriovenous he-teraction between diffusion and convection in CAVHD modialysis. Each total clearance point (1) has its corresponding convec-
[4]. A 0.4 m2 hemofilter was used in conjunction with a tive component (s) plotted directly below it; one point (d) was not
included in the regression because of a very low blood flow and lackconstant dialysate flow rate of 1 liter/hr (providing approx-
of membrane equilibrium. Reprinted with permission from the Interna-imately 17 ml/min of diffusive clearance) and ultrafiltra- tional Society of Nephrology [4].
tion rates ranging from 4 to 13 ml/min. The convective
clearance associated with a specific ultrafiltration rate
was determined by subtracting diffusive clearance from
the (measured) total clearance. Figure 1 provides several separate diffusive and convective components (based on
the dialysate flow and ultrafiltration rates, respectively).lines of evidence indicating no interaction between diffu-
sion and convection under the specific conditions of this Even at the combination of dialysate flow and ultrafiltra-
tion rates of 2.5 and 2.0 liter/hr, respectively, the differ-study. First, the relationship between total clearance and
ultrafiltration rate is linear and the separate curves for ences between the actual and predicted solute clearances
for urea, creatinine, uric acid, and phosphate were mini-total clearance and convective clearance are parallel.
Second, providing an internal check of consistency of mal (,5%). These data suggest the prescription of rela-
tively high flow rates still results in no significant interac-the data set, extrapolation of the total clearance curve
to the case of pure diffusion (QF 5 0) results in the tion between diffusion and convection in CVVHDF, at
least when a large surface area hemofilter is used.expected y-intercept value of approximately 17 ml/min.
Although these data pertain to CAVHD, they are also
Effect of high dialysate flow rates on small soluteapplicable to CVVHD performed under similar treat-
removal efficiency in CVVHDment conditions.
Whereas a dialysate flow rate of 1 liter/hr was fairly In the Sigler and Teehan study, a dialysate flow rate
of 1 liter/hr resulted in an effluent dialysate/plasma con-typical for CAVHD/CAVHDF and CVVHD/CVVHDF
for several years, flow rates of 1.5 to 2 liter/hr are now centration ratio (D/P) of approximately 1 such that effec-
tive “saturation” of the effluent dialysate was achievedcommonly used. Because this use of higher flow rates has
increased the efficiency of diffusive small solute removal, [4]. This saturation phenomenon appears to be depen-
dent on both dialysate flow rate and filter surface area.diffusion and convection may interact. Brunet et al have
recently assessed this possibility [7]. These investigators Using a 0.6 m2 AN69 filter, Bonnardeaux et al measured
clearance and D/P for urea and creatinine over a dialy-measured the clearance of urea, creatinine, uric acid,
phosphate, and b2-microglobulin (b2m) over a wide range sate flow rate (QD) range of 0 to 4 liter/hr [8]. For both
solutes, the relationship between clearance and QD wasof dialysate flow rates (0 to 2.5 liter/hr) and ultrafiltration
rates (0 to 2 liter/hr) in pre-dilution CVVHDF employing linear for the QD range of 0 to 2 liter/hr, after which there
was a plateau effect for both solutes. Although D/P waseither a 0.6 or 0.9 m2 hemofilter. These measured clear-
ances were compared to those predicted by adding the approximately 1 for both solutes at a QD 1 liter/hr, it
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progressively fell as QD increased, reaching a value of ity of pre-dilution CVVH to deliver therapy doses that
far exceed those achieved with post-dilution systems.approximately 0.87 and 0.79 at QD 2 liter/hr and 0.65 and
0.55 at QD 4 liter/hr for urea and creatinine, respectively.
Using the same filter, Relton, Greenberg and Palevsky
REMOVAL OF MIDDLE- AND LARGE-SIZED
reported mean urea D/P values of 0.99 and 0.87 at QD MOLECULES IN CRRT
1 and 2 liter/hr, respectively, while the same values for
Middle molecule removal in CRRTcreatinine were 0.84 and 0.66 [5].
In a more recent study, Brunet et al assessed the role For the characterization of dialyzer performance, vita-
min B12 (molecular weight, 1355 daltons) is widely usedof filter surface area on solute clearances in CVVHD
[7]. These investigators measured clearances of urea, as an in vitro middle molecule surrogate. However, this
solute has little relevance in in vivo dialyzer evaluationscreatinine, urate, and phosphate over a QD range of 0
to 2.5 liter/hr for AN69 filters of surface area 0.6 and due to its extensive plasma protein binding. A more rele-
vant middle molecule is vancomycin (molecular weight,0.9 m2. At QD 1 liter/hr, membrane surface area had no
significant effect on the clearance of any solute. How- 1448 daltons) for several reasons. First, the drug is com-
monly used in patients with ARF and assays for serumever, at QD 2.5 liter/hr, the clearances of urea, creatinine,
urate, and phosphate were 6%, 15%, 18%, and 16% concentration are widely available. Second, vancomycin
is minimally protein-bound in patients with renal failurehigher, respectively, with the larger surface area filter.
These data indicate that the efficiency of small solute [10] and available to be removed by extracorporeal tech-
niques. Finally, the drug’s volume of distribution is wellremoval during high-flow rate CVVHD is enhanced by
the use of relatively large surface area filters. characterized [11] and, although it has a slightly larger
range, it approximates that of urea.
Pre-dilution versus post-dilution CVVH: Effect on In IHD, although vancomycin removal by low-flux
small solute removal dialyzers is negligible, substantial diffusive elimination
is achieved with high permeability membranes [12–17].In CVVH, the method by which replacement fluids
are administered influences small solute removal effi- During high-flux HD, vancomycin mass transfer between
well perfused compartments of the body (for example,ciency. In post-dilution CVVH, small solute mass re-
moval per unit volume of ultrafiltrate is relatively high extracellular space) and poorly perfused compartments
(intracellular space) is slow relative to the rate of massbecause solute concentrations within the filter are the
same as in the plasma water. However, the volumetric transfer across the dialyzer. The clinical manifestation
of this phenomenon is a significant rebound in the plasmarate of ultrafiltrate production is limited by the operating
characteristics of the system, mainly the hematocrit (vis- vancomycin concentration during the immediate post-
HD period [18]. Due to the much slower rate of extracor-cosity) and blood flow (shear) rate that exist in the filter.
In general, the maximum achievable ultrafiltration rate poreal removal of vancomycin during CRRT, the dis-
equilibrium between body compartments described abovein a post-dilution system is limited to approximately 25%
of the plasma flow rate through the filter [9]. Because for high-flux IHD is predicted to be an insignificant factor.
The diffusivity of a solute, whether in solution or in anultrafiltration rate and clearance are essentially equiva-
lent in a post-dilution system for small solutes, the maxi- extracorporeal membrane, is inversely proportional to its
molecular weight. Consequently, as solute molecularmum clearance achievable in a patient with a hematocrit
of 0.30 and treated with a blood flow rate of 150 ml/min weight increases, diffusion becomes a relatively ineffi-
cient dialytic removal mechanism and the relative impor-is approximately 26 ml/min.
In pre-dilution CVVH, small solute removal per unit tance of convection increases. Jeffrey et al have recently
shown that convection is quantitatively more importantvolume of ultrafiltrate is less because solute concentra-
tions in the filter are lower than those in the plasma than diffusion in vancomycin removal when the same
ultrafiltration rate (CVVH) and effluent dialysate flowwater. For urea, the degree to which this “dilution” re-
duces the filter solute concentrations is proportional to rate (CVVHD) of 25 ml/min (1.5 liter/hr) is used [19].
the ratio of the dilution fluid administration rate divided
Removal of inflammatory mediators and other plasmaby the total blood water flow rate through the filter.
proteins in CRRTUnder most circumstances of contemporary CVVH, this
dilution factor and the associated reduction in efficiency The identification of b2m as a precursor molecule in
the development of dialysis-related amyloidosis estab-is approximately 10 to 15%. However, the ultrafiltration
rate in a pre-dilution system is not constrained by viscos- lished low-molecular weight proteins as a new class of
uremic toxins [20]. In response to this discovery, signifi-ity and shear rate, and the modest decrease in efficiency
related to the dilution of filter small solute concentra- cant effort has been directed toward developing mem-
branes and treatment strategies that optimize b2m re-tions can easily be overcome by the use of a relatively
high ultrafiltration rate. These principles explain the abil- moval. However, efforts to enhance b2m removal by
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Fig. 2. Effect of continuous venovenous he-
mofiltration on hemodynamic parameters in
patients with septic shock. Symbols are: (j)
cardiac output; (m) pulmonary artery occlu-
sion pressure; (.) systemic vascular resis-
tance. Reprinted with permission from the
American Society of Nephrology [22].
increasing membrane permeability have been limited by in systemic vascular resistance were observed during this
early time period (Fig. 2). Particularly at early timethe concomitant need to minimize the loss of other pro-
teins, such as albumin [21]. points, adsorption accounted for the majority of cytokine
removal and, in the specific case of interleukin (IL)-In some critically ill patients with ARF, low-molecular
weight proteins also represent a class of molecules con- 10, was the only removal mechanism at any time point.
However, the rate of adsorptive removal decreased rap-sidered “toxic.” However, specifically in the case of pa-
tients with sepsis or multi-system organ failure, the spe- idly thereafter, suggesting a saturable phenomenon and
corroborating previous data [23]. Because the CVVHcific toxins are inflammatory mediators, such as cytokines
and complement pathway products. The issue of in- mode was post-dilution, mean ultrafiltration rate was
significantly higher at Qb 5 200 versus Qb 5 100 ml/flammatory mediator removal with CRRT has been the
topic of numerous recent investigations [22–29]. These min (44.3 6 1.5 vs. 25.4 6 0.7 ml/min, respectively).
Under the higher blood flow and ultrafiltration rate con-studies have convincingly demonstrated that a number
of inflammatory mediators can be removed by convec- dition, the convective removal rate of all cytokines in-
creased along with the adsorptive removal rate of mosttion or adsorption during CRRT. However, data indicat-
ing that the ability to remove these mediators translates cytokines. These data suggest that the combination of a
relatively high ultrafiltration rate and frequent filterinto lowered plasma concentrations are not nearly as
convincing. changes results in clinically measurable decreases in sys-
temic cytokine concentrations.De Vriese et al recently performed an elegant study
addressing the issue of cytokine removal during CRRT The above data indicate that adsorption is the primary
mechanism by which cytokine removal occurs during[22]. In patients receiving CVVH with AN69 filters
(0.9 m2), these investigators quantified removal of nu- post-dilution CVVH performed with an AN69 hemo-
filter. It should be emphasized that this finding may notmerous pro-inflammatory and anti-inflammatory cyto-
kines and the effect on plasma concentrations. The study pertain to hemofiltration performed with other filters.
Indeed, although convective cytokine removal appeareddesign consisted of using two filters sequentially, each
for 12 hours, at blood flow rates of 100 and 200 ml/min, to play a relatively small role in the De Vries et al study,
studies employing other filters suggest convection is therespectively (or vice versa). Simultaneous sampling of
the arterial, venous, and ultrafiltrate lines at multiple primary elimination mechanism [24, 27]. Consequently,
there is a growing interest in the use of hemofiltrationtime points permitted mass balance assessments of ad-
sorptive versus convective removal. Cytokine removal therapies that use unconventional methods to enhance
convective removal of inflammatory mediators. Onewas found to be highest during the first hour of use of
a new filter, corresponding to approximately 25 to 50% technique involves use of ultrafiltration rates (4 liter/hr
or more) that are significantly higher than those typicallyof the cytokine mass presented to the filter in this time
period. This resulted in a significant decrease in the se- used in clinical practice [24]. A second technique consists
of using a hemofilter which has a mean pore size that isrum concentration of all cytokines. In addition, a signifi-
cant decrease in cardiac output and a significant increase significantly larger than that of conventional hemofilters
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